Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 5/2020

01-10-2020 | Helicobacter Pylori | Case Report

The rare case of elevated signet ring cell gastric carcinoma with Helicobacter pylori-naïve mucosa

Authors: Yasutoshi Shiratori, Takashi Ikeya, Koyu Suzuki, Kenji Nakamura, Katsuyuki Fukuda

Published in: Clinical Journal of Gastroenterology | Issue 5/2020

Login to get access

Abstract

Patients with Helicobacter pylori-naive mucosa may develop a pale, depressed signet ring cell gastric carcinoma or elevated gastric phenotype carcinoma. Almost all signet ring cell carcinomas are of the flat or depressed type, and elevated lesions are rare. We experienced a case of elevated signet ring cell carcinoma with Helicobacter pylori-naïve mucosa. Although the lesion needed to be differentiated from nonepithelial tumor, we diagnosed early and treated with endoscopic submucosal dissection. We report our case along with the relevant literature review.
Literature
2.
go back to reference Yao K, Takaki Y, Matsui T, et al. Clinical application of magnification endoscopy and narrow-band imaging in the upper gastrointestinal tract: new imaging techniques for detecting and characterizing gastrointestinal neoplasia. Gastrointest Endosc Clin N Am. 2008;18:415–33.CrossRefPubMed Yao K, Takaki Y, Matsui T, et al. Clinical application of magnification endoscopy and narrow-band imaging in the upper gastrointestinal tract: new imaging techniques for detecting and characterizing gastrointestinal neoplasia. Gastrointest Endosc Clin N Am. 2008;18:415–33.CrossRefPubMed
3.
go back to reference Yasuda K, Adachi Y, Shiraishi N, et al. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3:33–8.CrossRefPubMed Yasuda K, Adachi Y, Shiraishi N, et al. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3:33–8.CrossRefPubMed
4.
go back to reference Pernot S, Voron T, Perkins G, et al. Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428–38.CrossRefPubMedPubMedCentral Pernot S, Voron T, Perkins G, et al. Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428–38.CrossRefPubMedPubMedCentral
6.
go back to reference Yamada A, Kaise M, Inoshita N, et al. Characterization of Helicobacter pylori-naive early gastric cancers. Digestion. 2018;98:127–34.CrossRef Yamada A, Kaise M, Inoshita N, et al. Characterization of Helicobacter pylori-naive early gastric cancers. Digestion. 2018;98:127–34.CrossRef
7.
go back to reference Hirano T, Yamaguchi S, Kusano H, et al. Signet ring cell early gastric cancer presenting as an elevated lesion. Gastroenterol Jpn. 1990;25:625–9.CrossRefPubMed Hirano T, Yamaguchi S, Kusano H, et al. Signet ring cell early gastric cancer presenting as an elevated lesion. Gastroenterol Jpn. 1990;25:625–9.CrossRefPubMed
8.
go back to reference Horiuchi Y, Fujisaki J, Yamamoto N, et al. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer. 2016;19:160–5.CrossRefPubMed Horiuchi Y, Fujisaki J, Yamamoto N, et al. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer. 2016;19:160–5.CrossRefPubMed
9.
go back to reference Yamamoto Y, Fujisaki J, Omae M, et al. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27:551–61.CrossRef Yamamoto Y, Fujisaki J, Omae M, et al. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27:551–61.CrossRef
10.
go back to reference Kato S, Matsukura N, Tsukada K, et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci. 2007;98:790–4.CrossRefPubMed Kato S, Matsukura N, Tsukada K, et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci. 2007;98:790–4.CrossRefPubMed
11.
go back to reference Mochizuki Y, Iwaya Y, Iwaya M, et al. A pedunculated signet-ring cell carcinoma of the stomach mimicking a hyperplastic polyp. Gastrointest Endosc. 2019;90:848–9.CrossRefPubMed Mochizuki Y, Iwaya Y, Iwaya M, et al. A pedunculated signet-ring cell carcinoma of the stomach mimicking a hyperplastic polyp. Gastrointest Endosc. 2019;90:848–9.CrossRefPubMed
12.
go back to reference Mizutani M, Iriguchi Y, Oda J, et al. A case of protruding gastric signet-ring cell carcinoma. Prog Dig Endosc. 2015;86:142–3.CrossRef Mizutani M, Iriguchi Y, Oda J, et al. A case of protruding gastric signet-ring cell carcinoma. Prog Dig Endosc. 2015;86:142–3.CrossRef
Metadata
Title
The rare case of elevated signet ring cell gastric carcinoma with Helicobacter pylori-naïve mucosa
Authors
Yasutoshi Shiratori
Takashi Ikeya
Koyu Suzuki
Kenji Nakamura
Katsuyuki Fukuda
Publication date
01-10-2020
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 5/2020
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-020-01138-z

Other articles of this Issue 5/2020

Clinical Journal of Gastroenterology 5/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.